Covid-19: US agencies call for pause in Johnson & Johnson vaccine
US health authorities are calling for a pause in the use of the Johnson & Johnson Covid-19 vaccine, after reports of ext...
You are offline
The US, South Africa and European Union have said they are temporarily halting the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting. This comes after six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said. This week, Johnson & Johnson had begun its EU vaccine rollout but has now paused it. It follows similar cases after doses of the AstraZeneca vaccine, which prompted curbs to its use. The FDA said it was recommending the temporary pause "out of an abundance of caution". It confirmed that one patient died from blood clotting complications, and another is in a critical condition. All six cases were in women aged between 18 and 48, with symptoms appearing six to 13 days after vaccination.Relating this to the good health and well-being SDG, is halting the vaccine rollout in the best interests of the good health and well-being of people? Tell us your thoughts!Â
View SourceRelated Notices
World Health Organization grants emergency use authorization to Johnson & Johnson vaccine
The World Health Organization on Friday granted emergency use authorization to the COVID-19 vaccine developed by Johnson...
Uganda declares Ebola outbreak after finding rare Sudan strain.
A flare-up of Ebola has been proclaimed in Uganda after health authorities affirmed a case of the generally uncommon Sud...
This notice has been removed
The content is no longer available
Johnson & Johnson vaccine paused over rare blood clots
The US, South Africa and European Union have said they are temporarily halting the rollout of the Johnson & Johnson (J&J) Covid jab, after reports of rare blood clotting. This comes after six cases were detected in more than 6.8 million doses of the vaccine, the US Food and Drug Administration (FDA) said. This week, Johnson & Johnson had begun its EU vaccine rollout but has now paused it. It follows similar cases after doses of the AstraZeneca vaccine, which prompted curbs to its use. The FDA said it was recommending the temporary pause "out of an abundance of caution". It confirmed that one patient died from blood clotting complications, and another is in a critical condition. All six cases were in women aged between 18 and 48, with symptoms appearing six to 13 days after vaccination.Relating this to the good health and well-being SDG, is halting the vaccine rollout in the best interests of the good health and well-being of people? Tell us your thoughts!Â
Recent Searches
Recent Noticeboards
Trending
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Discussion (0)
No comments yet